ID   PI4KA_RAT               Reviewed;        2096 AA.
AC   O08662; A0A0G2K2J3;
DT   19-MAR-2014, integrated into UniProtKB/Swiss-Prot.
DT   17-FEB-2016, sequence version 2.
DT   24-JUL-2024, entry version 160.
DE   RecName: Full=Phosphatidylinositol 4-kinase alpha;
DE            Short=PI4-kinase alpha;
DE            Short=PI4K-alpha;
DE            Short=PtdIns-4-kinase alpha;
DE            EC=2.7.1.67 {ECO:0000269|PubMed:8662589};
GN   Name=Pi4ka; Synonyms=Pik4ca;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 53-2096, CATALYTIC ACTIVITY, TISSUE
RP   SPECIFICITY, SUBCELLULAR LOCATION, AND ACTIVITY REGULATION.
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=8662589; DOI=10.1074/jbc.271.20.12088;
RA   Nakagawa T., Goto K., Kondo H.;
RT   "Cloning, expression, and localization of 230-kDa phosphatidylinositol 4-
RT   kinase.";
RL   J. Biol. Chem. 271:12088-12094(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   GENE STRUCTURE.
RX   PubMed=23229899; DOI=10.1083/jcb.201206095;
RA   Nakatsu F., Baskin J.M., Chung J., Tanner L.B., Shui G., Lee S.Y.,
RA   Pirruccello M., Hao M., Ingolia N.T., Wenk M.R., De Camilli P.;
RT   "PtdIns4P synthesis by PI4KIIIalpha at the plasma membrane and its impact
RT   on plasma membrane identity.";
RL   J. Cell Biol. 199:1003-1016(2012).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-254; SER-259 AND SER-1430,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Acts on phosphatidylinositol (PtdIns) in the first committed
CC       step in the production of the second messenger inositol-1,4,5,-
CC       trisphosphate. {ECO:0000269|PubMed:8662589}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) + ATP = a
CC         1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate) + ADP +
CC         H(+); Xref=Rhea:RHEA:19877, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:57880, ChEBI:CHEBI:58178, ChEBI:CHEBI:456216;
CC         EC=2.7.1.67; Evidence={ECO:0000269|PubMed:8662589};
CC   -!- ACTIVITY REGULATION: Activated by Triton X-100, insensitive to
CC       inhibition by adenosine and inhibited by wortmannin (PubMed:8662589).
CC       The PI4K complex acts as a regulator of phosphatidylinositol 4-
CC       phosphate (PtdIns(4)P) synthesis (By similarity). Interaction with
CC       TMEM150A regulates PtdIns(4)P synthesis (By similarity).
CC       {ECO:0000250|UniProtKB:P42356, ECO:0000269|PubMed:8662589}.
CC   -!- SUBUNIT: Component of a phosphatidylinositol 4-kinase (PI4K) complex,
CC       composed of PI4KA, EFR3 (EFR3A or EFR3B), TTC7 (TTC7A or TTC7B) and
CC       HYCC (HYCC1 or HYCC2). Interacts with TMEM150A; regulating recruitment
CC       to the plasma membrane. Interacts with TTC7A.
CC       {ECO:0000250|UniProtKB:P42356}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P42356}. Cell
CC       membrane {ECO:0000250|UniProtKB:P42356}. Note=Localization to the
CC       plasma membrane is mediated by the PI4K complex and association with
CC       EFR3 (EFR3A or EFR3B), TTC7 (TTC7A or TTC7B) and HYCC (HYCC1 or HYCC2).
CC       Localization to the plasma membrane is regulated by TMEM150A.
CC       {ECO:0000250|UniProtKB:P42356}.
CC   -!- TISSUE SPECIFICITY: Detected in the brain, kidney and lung. Less
CC       intensely expressed in the small intestine, uterus, adrenal gland,
CC       heart, skeletal muscle, thymus, spleen and testis.
CC       {ECO:0000269|PubMed:8662589}.
CC   -!- DEVELOPMENTAL STAGE: In brain of prenatal day 18 embryos, the
CC       expression is detected throughout the mantle zone of fore-, mid-, and
CC       hind brain. In the cerebrum, the expression is intense in the cortical
CC       plate and weak in the ventricular zone. At P49, expressed in the gray
CC       matter of the entire brain by hippocampal pyramidal cells, dentate
CC       granule cells, and cerebellar granule cells and to a lower extent by
CC       olfactory mitral and granule cells and the cerebral cortex. Weakly
CC       expressed in the diencephalon and brain stem and not detected in the
CC       cerebellar medulla. Expression is much higher in the fetal brain than
CC       the adult brain, especially in the brain stem.
CC       {ECO:0000269|PubMed:8662589}.
CC   -!- SIMILARITY: Belongs to the PI3/PI4-kinase family. Type III PI4K
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D83538; BAA19614.1; -; mRNA.
DR   EMBL; AC111344; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_071637.1; NM_022301.1.
DR   AlphaFoldDB; O08662; -.
DR   SMR; O08662; -.
DR   BioGRID; 248988; 3.
DR   IntAct; O08662; 8.
DR   MINT; O08662; -.
DR   STRING; 10116.ENSRNOP00000072265; -.
DR   CarbonylDB; O08662; -.
DR   iPTMnet; O08662; -.
DR   PhosphoSitePlus; O08662; -.
DR   jPOST; O08662; -.
DR   PaxDb; 10116-ENSRNOP00000059384; -.
DR   AGR; RGD:621213; -.
DR   RGD; 621213; Pi4ka.
DR   eggNOG; KOG0902; Eukaryota.
DR   InParanoid; O08662; -.
DR   OrthoDB; 147843at2759; -.
DR   Reactome; R-RNO-1483248; Synthesis of PIPs at the ER membrane.
DR   Reactome; R-RNO-1660514; Synthesis of PIPs at the Golgi membrane.
DR   PRO; PR:O08662; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0030660; C:Golgi-associated vesicle membrane; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0004430; F:1-phosphatidylinositol 4-kinase activity; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; ISO:RGD.
DR   GO; GO:0044788; P:modulation by host of viral process; ISO:RGD.
DR   GO; GO:0046854; P:phosphatidylinositol phosphate biosynthetic process; ISO:RGD.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; IBA:GO_Central.
DR   GO; GO:0140754; P:reorganization of cellular membranes to establish viral sites of replication; ISO:RGD.
DR   CDD; cd00871; PI4Ka; 1.
DR   CDD; cd05167; PI4Kc_III_alpha; 1.
DR   Gene3D; 1.10.1070.11; Phosphatidylinositol 3-/4-kinase, catalytic domain; 1.
DR   Gene3D; 1.25.40.70; Phosphatidylinositol 3-kinase, accessory domain (PIK); 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000403; PI3/4_kinase_cat_dom.
DR   InterPro; IPR036940; PI3/4_kinase_cat_sf.
DR   InterPro; IPR018936; PI3/4_kinase_CS.
DR   InterPro; IPR001263; PI3K_accessory_dom.
DR   InterPro; IPR042236; PI3K_accessory_sf.
DR   InterPro; IPR045495; PI4K_N.
DR   InterPro; IPR015433; PI_Kinase.
DR   PANTHER; PTHR10048:SF15; PHOSPHATIDYLINOSITOL 4-KINASE ALPHA; 1.
DR   PANTHER; PTHR10048; PHOSPHATIDYLINOSITOL KINASE; 1.
DR   Pfam; PF00454; PI3_PI4_kinase; 1.
DR   Pfam; PF00613; PI3Ka; 1.
DR   Pfam; PF19274; PI4K_N; 2.
DR   SMART; SM00145; PI3Ka; 1.
DR   SMART; SM00146; PI3Kc; 1.
DR   SUPFAM; SSF48371; ARM repeat; 2.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00915; PI3_4_KINASE_1; 1.
DR   PROSITE; PS00916; PI3_4_KINASE_2; 1.
DR   PROSITE; PS50290; PI3_4_KINASE_3; 1.
DR   PROSITE; PS51545; PIK_HELICAL; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Cytoplasm; Kinase; Lipid metabolism; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Transferase.
FT   CHAIN           1..2096
FT                   /note="Phosphatidylinositol 4-kinase alpha"
FT                   /id="PRO_0000425713"
FT   DOMAIN          1524..1712
FT                   /note="PIK helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00878"
FT   DOMAIN          1802..2080
FT                   /note="PI3K/PI4K catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1808..1814
FT                   /note="G-loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          1948..1956
FT                   /note="Catalytic loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          1967..1991
FT                   /note="Activation loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   MOD_RES         224
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P42356"
FT   MOD_RES         250
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P42356"
FT   MOD_RES         251
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P42356"
FT   MOD_RES         253
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q3L2"
FT   MOD_RES         254
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         256
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P42356"
FT   MOD_RES         259
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         423
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P42356"
FT   MOD_RES         1430
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CONFLICT        186
FT                   /note="R -> K (in Ref. 1; BAA19614)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        631..633
FT                   /note="Missing (in Ref. 1; BAA19614)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2096 AA;  236920 MW;  8CB6D0DA792F9694 CRC64;
     MAAAGARGTG GSGSSSGSST SRGFYFNTVL SLARSLAVQR PASLEKVQKL LCMCPVDFHG
     IFQLDERRRD AVIALGIFLI ESDLQHKDCI VPYLLRLLRG LPKVYWVEES TARKGRGNLP
     VAESFSFCLV TLLSDVACRD PSLRDEILEA LLQVLHVLLG MCQALEIQEK EYLCKYAIPC
     LIGISRSFGR YSNSEESLLS KLFPKVPPHS LRIPEELEGV RRRSFNDFRS ILPSNLLTVC
     QEGTLKRKTS SVSSISQVSP ERGMPPPSSP GGSAFHYFEA SCLPDGTTLE PEYYFSTISS
     SFSVSPLFNG ITYKEFYIPL EMLRELLNLV KKIVEEPVLK SLDAAVARVM EANPSADLYY
     TTFSDPVYLT MFKMLRDTLY YMKDLPTSFV KEIHDFVLEQ FNMSQGELQK ILHDADRIHS
     EMSPLKLRCQ ANAACVDLMV WAVKDEQGAE NLCIKLSEKL QSKTSSKVII AHLPLLICCL
     QGLGRLCERF PVVVHSVTPS LRDFLVIPSP VLVKLYKYHS QYHTVAGSDI KISVTNEHSE
     STLNVLPGKK NQPSMYEQLR DIAIDNICRC LKAGLTVDPV IVEAFLASLS NRLYISQESD
     KDAHLIPDHT IRALGHIAVA LRDTPKVMEP ILQILQQKFC QPPSPLDVLI IDQLGCLVIT
     GNQYIYQEVW NLFQQISVKA SSVVYSATKD YKDHGYRHCS LAVINALANI AANIQEEHLV
     DELLMNLLEL FVQLGLEGKR ASERASEKGP ALKASSSAGN LGVLIPVIAV LTRRLPPIKE
     AKPRLQKLFR DFWLYSVLMG FAVEGSGLWP EEWYEGVCEI ATKSPLLTFP SKEPLRSVLQ
     YNSAMKNDTV TPAELNELRS TIINLLDPPP EVSALINKLD FAMSTYLLSV YRLEYMRVLR
     STDPDRFQVM FCYFEDKAIQ KDKSGMMQCV IAVADKVFDA FLNMMAEKAK TKENEEELER
     HAQFLLVNFN HIHKRIRRVA DKYLSGLVDK FPHLLWSGTV LKTMLDILQT LSLSLSADIH
     KDQPYYDIPD APYRITVPDT YEARESIVKD FAARCGMILQ EAMKWAPTVT KSHLQEYLNK
     HQNWVSGLSQ HTGLAMATES ILHFAGYNKQ NTTLGVTQLT ERPACVKKDY SNFMASLNLR
     NRYAGEVHGM IRFSGATGQM SDLNKMMVQD LITALDHSHP QHYTQAMFKL TAMLISSKDC
     DPQLLHHLCW GPLRMFNEHG METALACWEW LLAGKNGVEV PFMREMAGAW HMTVEQKFGL
     FSAETKEADP LAASEASQPR PCPPEVTPHY IWIDFLVQRF EIAKYCSSDQ VEIFSSLLQR
     SMSLHIGGAR GSMNRHVAAI GPRFKLLTLG LSLLHADVVP NATIRNVLRE KIYSTAFDYF
     SCPPKFPTQG EKRLREDISI MIKFWTAMFS DKKYLTASQL VPPDNQDTRS NLDITVGSRQ
     QATQGWINTY PLSSGMSTIS KKSGMSKKTN RGSQLHKYYM KRRTLLLSLL ATEIERLITW
     YNPLSAPELE LDQAGENSVA NWRSKYISLS EKQWKDNVNL AWTISPYLAV QLPARFKNTE
     AIGNEVTRLV RLDPGAVSDV PEAIKFLVTW HTIDADAPEL SHVLCWAPTD PPTGLSYFSS
     MYPPHPLTAQ YGVKVLRSFP PDAILFYIPQ IVQALRYDKM GYVREYILWA AAKSQLLAHQ
     FIWNMKTNIY LDEEGHQKDP DIGDLLEQLV EEITGSLSGP AKDFYQREFD FFNKITNVSA
     IIKPYPKGDE RKKACLSALS EVKVQPGCYL PSNPEAIVLD IDYKSGTPMQ SAAKAPYLAK
     FKVKRCGVSE LEKEGLQCRS DTEDECRRQE ADGKKICWQA AIFKVGDDCR QDMLALQIID
     LFKNIFQLVG LDLFVFPYRV VATAPGCGVI ECIPDCTSRD QLGRQTDFGM YDYFTRQYGD
     ESTLAFQQAR YNFIRSMAAY SLLLFLLQIK DRHNGNIMLD KKGHIIHIDF GFMFESSPGG
     NLGWEPDIKL TDEMVMIMGG KMEATPFKWF MEMCVRGYLA VRPYMDAVVS LVTLMLDTGL
     PCFRGQTIKL LKHRFSPNMT EREAANFIMK IIQNCFLSNR SRTYDMIQYY QNDIPY
//
